HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage
- PMID: 10073943
- DOI: 10.1126/science.283.5408.1748
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage
Abstract
A selective advantage against infectious disease associated with increased heterozygosity at the human major histocompatibility complex [human leukocyte antigen (HLA) class I and class II] is believed to play a major role in maintaining the extraordinary allelic diversity of these genes. Maximum HLA heterozygosity of class I loci (A, B, and C) delayed acquired immunodeficiency syndrome (AIDS) onset among patients infected with human immunodeficiency virus-type 1 (HIV-1), whereas individuals who were homozygous for one or more loci progressed rapidly to AIDS and death. The HLA class I alleles B*35 and Cw*04 were consistently associated with rapid development of AIDS-defining conditions in Caucasians. The extended survival of 28 to 40 percent of HIV-1-infected Caucasian patients who avoided AIDS for ten or more years can be attributed to their being fully heterozygous at HLA class I loci, to their lacking the AIDS-associated alleles B*35 and Cw*04, or to both.
Comment in
- Science. 1999 Jul 2;285(5424):11
Similar articles
-
HLA and AIDS: a cautionary tale.Trends Mol Med. 2001 Sep;7(9):379-81. doi: 10.1016/s1471-4914(01)02131-1. Trends Mol Med. 2001. PMID: 11530315
-
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.J Virol. 2001 Sep;75(18):8681-9. doi: 10.1128/jvi.75.18.8681-8689.2001. J Virol. 2001. PMID: 11507213 Free PMC article. Clinical Trial.
-
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5140-5. doi: 10.1073/pnas.071548198. Epub 2001 Apr 17. Proc Natl Acad Sci U S A. 2001. PMID: 11309482 Free PMC article.
-
Progression of HIV to AIDS: a protective role for HLA-B27?AIDS Rev. 2004 Apr-Jun;6(2):89-96. AIDS Rev. 2004. PMID: 15332431 Review.
-
[Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].Rev Invest Clin. 2000 May-Jun;52(3):284-95. Rev Invest Clin. 2000. PMID: 10953612 Review. Spanish.
Cited by
-
Rapid HIV progression during acute HIV-1 subtype C infection in a Mozambican patient with atypical seroconversion.Am J Trop Med Hyg. 2015 Apr;92(4):681-3. doi: 10.4269/ajtmh.14-0554. Epub 2015 Jan 26. Am J Trop Med Hyg. 2015. PMID: 25624400 Free PMC article.
-
Molecular signatures of T-cell inhibition in HIV-1 infection.Retrovirology. 2013 Mar 20;10:31. doi: 10.1186/1742-4690-10-31. Retrovirology. 2013. PMID: 23514593 Free PMC article. Review.
-
Co-operative additive effects between HLA alleles in control of HIV-1.PLoS One. 2012;7(10):e47799. doi: 10.1371/journal.pone.0047799. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094091 Free PMC article.
-
Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.Cell Syst. 2020 Oct 21;11(4):412-417.e2. doi: 10.1016/j.cels.2020.08.011. Epub 2020 Sep 10. Cell Syst. 2020. PMID: 32916095 Free PMC article.
-
Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion.J Biol Chem. 2013 Jun 14;288(24):17812-22. doi: 10.1074/jbc.M113.468975. Epub 2013 May 2. J Biol Chem. 2013. PMID: 23640893 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
